ACM
BOLD

Altium Capital Management’s Boundless Bio BOLD Stock Holding History

Altium Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,149
Closed -$322K – 97
2024
Q2 		$322K Sell
83,149
-116,851
-58% -$1.12M 0.13% 43
2024
Q1 		$2.85M Buy
+200,000
New +$2.85M 1.13% 29

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Altium Capital Management's BOLD Position: Q3 2024 in Review

Altium Capital Management sold out of Boundless Bio (BOLD) in Q3 2024, closing a stake of 83,149 shares — an estimated $322K sold.

Altium Capital Management first reported a position in BOLD in Q1 2024 and held it in 2 quarters. The position peaked at $2.85M in Q1 2024. 55 funds tracked by Wall St. Rank hold BOLD as of Q3 2024.

  • Altium Capital Management reported no remaining Boundless Bio position as of Q3 2024 after selling out during the quarter.
  • Altium Capital Management sold 83,149 Boundless Bio shares in Q3 2024, an estimated $322K.
  • Altium Capital Management first reported a position in Boundless Bio in Q1 2024 and held it in 2 quarters.
  • Altium Capital Management's Boundless Bio position peaked at $2.85M in Q1 2024.
  • 55 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2024.

Based on Altium Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.